HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luc Furic Selected Research

Peptide Initiation Factors (Initiation Factor)

3/2011Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.
11/2009p53-dependent translational control of senescence and transformation via 4E-BPs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luc Furic Research Topics

Disease

18Neoplasms (Cancer)
01/2023 - 11/2009
15Prostatic Neoplasms (Prostate Cancer)
01/2022 - 08/2010
4Carcinoma (Carcinomatosis)
01/2018 - 12/2010
3Neoplasm Metastasis (Metastasis)
01/2022 - 03/2011
3Carcinogenesis
11/2016 - 11/2009
2Disease Progression
06/2019 - 01/2018
1Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2021
1Breast Neoplasms (Breast Cancer)
06/2021
1Adenocarcinoma
01/2021
1Hypertrophy
01/2019
1Hematologic Neoplasms (Hematological Malignancy)
11/2016
1Virus Diseases (Viral Diseases)
04/2012
1Prostatic Diseases
01/2012
1Glioblastoma (Glioblastoma Multiforme)
12/2010
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2010
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2010

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
06/2021 - 08/2010
5Eukaryotic Initiation Factor-4EIBA
04/2012 - 11/2009
4AndrogensIBA
07/2020 - 01/2012
3ProteomeIBA
01/2023 - 12/2019
3Androgen Receptors (Androgen Receptor)IBA
11/2021 - 11/2018
3Hormones (Hormone)IBA
06/2021 - 09/2014
3Phosphotransferases (Kinase)IBA
01/2018 - 03/2011
2RNA Polymerase I (Polymerase I, RNA)IBA
11/2021 - 11/2016
2CX 5461IBA
11/2021 - 11/2016
2Estrogen ReceptorsIBA
06/2021 - 01/2015
2abirateroneIBA
01/2021 - 11/2018
2RNA (Ribonucleic Acid)IBA
01/2021 - 11/2016
2enzalutamideIBA
01/2021 - 11/2018
2Estrogen Receptor alphaIBA
12/2019 - 01/2015
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
08/2019 - 06/2019
2proto-oncogene proteins pimIBA
01/2018 - 11/2016
2Peptide Initiation Factors (Initiation Factor)IBA
03/2011 - 11/2009
1MTOR InhibitorsIBA
01/2023
1Radioisotopes (Radionuclides)IBA
01/2022
1PSMA I&TIBA
01/2022
1CalciumIBA
01/2022
1Radium-223IBA
01/2022
1talazoparibIBA
11/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2021
1Transcription Factors (Transcription Factor)IBA
06/2021
1Gonadal Steroid Hormones (Sex Hormones)IBA
06/2021
1lysophosphatidylinositolIBA
07/2020
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
07/2020
1Adenosine Triphosphate (ATP)IBA
07/2020
1Docetaxel (Taxotere)FDA Link
07/2020
1Cysteine (L-Cysteine)FDA Link
01/2020
1Prorenin ReceptorIBA
08/2019
1Adenosine Triphosphatases (ATPase)IBA
08/2019
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
08/2019
1TensinsIBA
08/2019
1Therapeutic UsesIBA
01/2019
1TOR Serine-Threonine KinasesIBA
01/2019
1LipidsIBA
01/2019
1Fatty Acids (Saturated Fatty Acids)IBA
01/2019
1Indicators and Reagents (Reagents)IBA
01/2018
1Mechanistic Target of Rapamycin Complex 1IBA
01/2018
1AMP-Activated Protein KinasesIBA
01/2018
1Ribosomal RNAIBA
11/2016
1CX-6258IBA
11/2016
1Glucose (Dextrose)FDA LinkGeneric
01/2015
1Estrogens (Estrogen)FDA Link
01/2015
1CytokinesIBA
09/2014
1AgarIBA
03/2011
1enzastaurinIBA
12/2010
1Messenger RNA (mRNA)IBA
11/2009

Therapy/Procedure

8Therapeutics
01/2022 - 03/2011
5Castration
01/2022 - 11/2016
2Drug Therapy (Chemotherapy)
01/2022 - 07/2020
1Prostatectomy (Retropubic Prostatectomy)
03/2021
1Oral Administration
11/2016